More than one third of the world's population (about 2 billion people) live in malaria-endemic areas, and 1 billion people are estimated to carry parasites at any one time.
Malaria, caused by protozoa of the genus Plasmodium, remains one of the most dreadful infectious diseases worldwide killing more than 1 million people per year. 2, 3) Lack of an effective vaccination and the spread of drug resistance necessitate the development of new drug targets. In the development of antimalarial drugs, it may be suitable to select targets from pathways present in the parasite but absent in humans. Nevertheless, even if a target was common to both parasite and host, slight structural differences could enhance the optimization of a new drug. 4) Thymidylate kinase (TMK, ATP : TMP phosphotransferase, dTMP kinase, deoxythymidine monophosphate kinase, EC 2.7.4.9) belongs to the nucleoside monophosphate kinase super-family and is critical for the synthesis of thymidine triphosphate (TTP). It catalyzes the reversible phosphorylation of TMP to its diphosphate form, thymidine diphosphate, in the presence of the divalent cation Mg 2Ϫ with ATP as the preferred phosphate donor.
Recently, we have reported that Plasmodium falciparum thymidylate kinase (PfTMK) is a promising chemotherapeutic target as it can tolerate a range of substrates, which distinguishes it from other TMKs. [5] [6] [7] [8] Compared with the human enzyme, PfTMK shows a broader spectrum of substrate specificity. The enzyme not only phosphorylates the pyrimidine nucleosides dTMP and dUMP, but can also tolerate the bulkier purines. PfTMK can utilize deoxyguanylate (dGMP), guanylate (GMP) and deoxyinosine monophosphate (dIMP). In our previous work, we clarified the dual purine and pyrimidine nucleoside monophosphate (NMP) kinase activity of PfTMK; based on catalytic, mutational, inhibitory, and nucleotide binding properties by isothermal titration calorimetry. Binding studies revealed that the binding affinity of both purine and pyrimidine substrates was highly comparable. Furthermore, PfTMK can be inhibited by both purine and pyrimidine nucleosides, raising the possibility of developing selective inhibitors against PfTMK. TMPK is important in nucleic acids synthesis because of the synthesis of thymidine triphosphate. Furthermore, targeting PfTMK is suspected to not only inhibit pyrimidine synthesis, but also can affect deoxyguanylate nucleotides synthesis.
Thermodynamic parameters associated with ligand binding are essential for a systematic evaluation of the binding of ligands with various affinities to a protein. An important step in drug discovery is the mapping of interactions of different substrates at their common active site. The thermodynamic parameters measured during the substrate binding or during competition with another ligand provide a good starting point of new compound design. In the cell, PfTMK is exposed to both substrates at the same time. In the present study, we examined the competitive binding affinity of PfTMK if exposed to an equimolar mixture of both substrates. Furthermore, there is an alteration of the binding properties of a ligand when another competing ligand is present. Therefore, we titrated one ligand in the presence of the enzyme bound with the other ligand to identify competitive binding and to determine the probability that one ligand can displace the other ligand from the binding site.
MATERIALS AND METHODS

Materials
Nucleosides and nucleotides were obtained from Sigma. Talon metal affinity resin was obtained from Clontech (Palo Alto, U.S.A.). Protein concentrations were determined using a protein assay reagent (Bio-Rad, U.S.A.) with bovine serum albumin as the standard. All chemicals used were of the highest quality available.
Production of Recombinant Enzyme PfTMK was prepared as previously described. 5) Briefly, the recombinant Escherichia coli cells were grown overnight in an LuriaBertani medium containing 50 mg/ml ampicillin. The culture was diluted to 1 : 100 with the same fresh medium and cells were grown at 37°C to mid-log phase (D 600 ϭ0.6). Induction of expression was carried out by the addition of isopropyl b-D-1-thiogalactopyranoside (IPTG) to a final concentration of 1 mM and cell growth was continued at 37°C for 4 h. Cells from 2 l of culture were harvested by centrifugation at 5000ϫg for 15 min and then stored at Ϫ20°C until use. To obtain the cell extract, cells were lysed in an extraction buffer (25 mM Tris-HCl buffer pH 7.2 containing 150 mM sodium chloride) and disintegrated by sonication for 40 s (3 cycles with 3 min intervals). The lysate was centrifuged at 16000ϫg for 15 min at 4°C and the precipitate discarded.
The hexahistidine-tagged PfTMK was purified from the soluble cell extract using a talon metal affinity resin. Flow rate was kept constant at 30 ml/min. After binding and washing with the extraction buffer, the protein was eluted using a linear imidazole gradient (from 0 to 150 mM).
Enzyme and Ligand Preparation The eluted protein fractions were pooled and concentrated. The concentrated fraction was extensively dialyzed against the 25 mM Tris-HCl buffer (pH 7.2) containing 2 mM ethylenediamine tetra-acetic acid (EDTA). The concentrated enzyme solution (about 5 ml) was dialyzed in 3 changes of 4 l of dialysis buffer at 4°C. Following dialysis, the enzyme solution was centrifuged to remove the insoluble material. The protein sample was diluted to the appropriate concentration with dialysis buffer immediately before titration. Substrate solution was made from the final dialysis buffer of proteins to minimize artifacts due to subtle differences in buffer composition.
Isothermal Titration Microcalorimetry (ITC) Calorimetric experiments were carried out using VP-ITC (MicroCal Inc., U.S.A.). The protein solution was loaded into a sample cell and equilibrated at the experimental temperature. Control experiments were performed by injecting the nucleotide into the dialysis buffer to determine the heat of dilution. In the usual ITC titrations, the ligand is placed in the syringe and used to titrate the macromolecule placed in the calorimetric cell. Thus by the usual ITC measurements, the available binding sites decrease gradually by continuous injection of the ligand.
The apparent heat change after each injection was determined by integration and corrected for the heat of dilution of the nucleotide. The data was fitted by non-linear regression analysis to yield the thermodynamic parameters K a , association constant; DH, enthalpy of binding; and n, the stoichiometry of binding. The affinity of the nucleotides to protein is given as the dissociation constant (K d ϭ1/K a ).
The binding entropy contributions were calculated from the equation DGϭDHϪTDS and DGϭϪRT ln K, where K is the association constant, T is the absolute temperature, DS is the entropy change, and DG is Gibb's free energy change.
Other Methods Protein concentration was determined using a protein assay reagent (Bio-Rad) with bovine serum albumin as the standard. The molecular mass of the recombinant enzyme was determined by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 12.5%. After electrophoresis, the gel was stained with Coomassie Brilliant Blue R-250. For Western blotting, purified PfTMK was applied to 12.5% SDS-PAGE, transferred to a polyvinylidene difluoride (PVDF) membrane, and detected by anti-His tag (10000-fold dilution). The immunoprobed proteins were detected using an horse-radish peroxidase (HRP) conjugated substrate detection kit. amount of heat produced following each injection. The bottom panel shows the integrated amount of heat generated per injection as a function of the molar ratio of ligand to enzyme.
RESULTS
Figures
We first determined the binding constant and the thermodynamic parameters of both pyrimidine and purine ligands, TMP and dGMP, respectively, with the free enzyme (Figs.  1A, B) . The thermodynamic parameters of direct titration were estimated by using a single set of binding sites model. Next, we repeated the same experiment by titrating one ligand in the presence of the enzyme bound with the other ligand to check competitive binding and to check the probability that one ligand can displace the other ligand from the binding site (Figs. 2A, B) . To determine the binding of PfTMK with an equimolar mixture of TMP and dGMP, the enzyme was placed into the cell and titrated with 1 mM mixture of both ligands (Fig. 1C) .
The ITC direct titration of PfTMK with TMP resulted in a binding constant, enthalpy and entropy of 7.2ϫ10 4 . Furthermore, titration of PfTMK/TMP with dGMP showed a very small heat signal corresponding to nonspecific background heat.
DISCUSSION
Binding of Nucleotides to the Free Enzyme
PfTMK is a key enzyme in the control of nucleotide metabolism and synthesis of DNA; furthermore, it is involved in the activation of various chemotherapeutic prodrugs. Currently little is known about the enzyme of substrate preference and enzyme-substrate recognition forces. Furthermore, the design of new substrates and chemotherapeutics requires accurate knowledge of the mode of interaction of a compound with the enzyme and the forces underlying this process. Thus, we used ITC to obtain information that could help to determine 
The data is an average of three different experiments. a) ND: non-detectable. the preferred nucleotides of PfTMK, estimate the nucleotide binding affinities, and quantify the thermodynamic parameters and the forces driving the nucleotide binding to PfTMK. Furthermore, we checked the behavior of ligand binding of the substrates with free enzymes as well as with a substrate bound to its active site.
The energetics of an interaction is important for determining the mechanisms of substrate-receptor complexes.
9,10) The binding of TMP was highly exothermic with a negative enthalpy change (DH) equal to Ϫ42.2 kcal/mol. In contrast, that of dGMP showed less exothermic interaction with a DH of Ϫ6.9 kcal/mol. The association of TMP with PfTMK was enthalpy-driven, showing that H-bonds and van der Waals interactions play a major role in the binding. The enthalpic force was opposed by strong non-favorable negative entropy.
Substrate Binding Preferences of PfTMK The interaction between a pharmacologic ligand and a macromolecular receptor complex is commonly quantified by measures of affinity as dissociation constant (K d ) or affinity constant (K a ), and furthermore, the interaction is characterized as the net attraction resulting from the making and breaking of multiple weak intermolecular bonds between ligand and receptor. 11) Binding affinities can be determined by using various techniques such as calorimetry, dialysis, ultracentrifugation, surface plasmon resonance, and spectroscopy. The ITC technique provides a unique capability in binding assays to detect interactions without any labeling and immobilization of either the enzyme or ligand. In the cell, PfTMK is exposed to both substrates at the same time. If the binding reaction is indeed the preferential process, i.e. one substrate overcomes the binding of the other, titration of PfTMK with a 1 : 1 mixture of dTMP and dGMP should yield a heat change corresponding to the parameters of the preferred nucleotide. In contrast, if both substrates can freely bind to the enzyme, titration of PfTMK with a 1 : 1 mixture of dTMP and dGMP should yield a binding affinity corresponding to the average of the binding affinity for individual reactions. If we consider TMP and dGMP as one ligand, in this case, the binding constant of 1 : 1 equimolar concentrations of TMP and dGMP (K TMPdGMP ) obtained from ITC equals (K TMP ϫK dGMP ) 1/2 where K TMP and K dGMP are the binding constants for TMP and dGMP with the free enzyme, respectively. The calculated K TMPdGMP equaled 5.9ϫ10 4 
M
Ϫ1
. Interestingly, the experimentally determined K TMPdGMP was highly comparable with that of the calculated one (5.7ϫ10 4 
M Ϫ1
). This result indicated that, the free enzyme can bind to both substrates without special preference to the natural substrate TMP over the unique substrate dGMP.
If A is the strongly binding ligand under investigation and B is a competitively inhibiting ligand, by using ITC, the less strongly bound ligand is competitively inhibiting the binding of the stronger ligand. When K A is similar to or smaller than K B , virtually no transition in the isotherm can be observed. This has only a relatively modest effect on the binding isotherm, making the transition somewhat shallower for the smaller values of K a . Furthermore, the enthalpy change of the test ligands must be significantly different from one another. 12) Weak exothermic signals can be detected by titration of PfTMK/dGMP complex with TMP. This indicates the ability of TMP to displace dGMP from its binding site of PfTMK. Although the K TMP is only one and a half times higher than that of K dGMP , an exothermic signal can be detected. The value of DH TMP ϪDH dGMP equals ca. Ϫ35 kcal/mol. The marked difference in the exothermic interaction of both ligands with PfTMK contributed to the detection of the exothermic property of TMP/dGMP displacement. The affinity constant of TMP with the free enzyme was calculated to be 7.2ϫ10 4 
M
Ϫ1 and the binding of TMP with PfTMK/dGMP complex was as low as 0.9ϫ10 4 
Ϫ1
, which lowered the binding affinity of TMP by a factor of ca. 8. In contrast, the titration of PfTMK/TMP with dGMP did not produce any interaction signals, indicating that dGMP was unable to displace TMP from the binding site.
CONCLUSION
From the results, we can conclude that the free PfTMK can bind with both TMP and dGMP if they are present in a mixture. Furthermore, dGMP was unable to displace TMP from its binding site. In contrast, TMP was able to partially displace dGMP from the binding site accompanied by a weak exothermic signal and lowered affinity. The results suggest that the synthesis of purine-based compounds as inhibitors of PfTMK will be highly selective for the parasitic enzyme; however, they need to be potent enough to displace TMP from its binding site. In addition, we believe that pyrimidine based inhibitors will compete with TMP and can more efficiently displace dGMP from the binding site compared with purine based compounds.
